Company Advanced Biomedical Technologies, Inc. Other OTC
Equities
ABMT
US00752M1018
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Polymer Osteosynthesis Devices
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +58.30% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +58.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hui Wang
CEO | Chief Executive Officer | 54 | - |
Kai Gui
DFI | Director of Finance/CFO | 54 | - |
Chi Ming Yu
CHM | Chairman | 50 | - |
Jin Hua Zeng
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sheng Puyi
CTO | Chief Tech/Sci/R&D Officer | 56 | 29/02/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Ming Yu
CHM | Chairman | 50 | - |
Hui Wang
CEO | Chief Executive Officer | 54 | - |
Kai Gui
DFI | Director of Finance/CFO | 54 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,904,850 | 68,554,850 ( 96.69 %) | 0 | 96.69 % |
Company contact information
Advanced BioMedical Technologies, Inc.
535 Fifth Avenue 4th floor
10017, New York
+
![address Advanced Biomedical Technologies, Inc.(ABMT)](https://cdn.zonebourse.com/static/address/5146528.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+5.16% | 213B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 113B | |
+3.73% | 64.85B | |
+20.08% | 55.17B | |
+1.51% | 49.1B | |
-4.27% | 38.83B | |
+0.88% | 35.6B |